SEC Form 4 · accession 0001179110-15-002829

HEALTH NET INC · HNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Frederick C Yeager

Director

Period of report

Feb 13, 2015

Accepted (ET)

Feb 18, 2015 · 6:12 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000916085

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F2	Feb 13, 2015	M	7,500	$32.59	A	24,675	D
Common Stock^F3,F2	Feb 13, 2015	S	7,500	$55.95	D	17,175	D
Common Stock^F2	Feb 13, 2015	M	7,500	$39.10	A	24,675	D
Common Stock^F5,F2	Feb 13, 2015	S	7,500	$55.99	D	17,175	D
Common Stock^F2	Feb 13, 2015	M	11,600	$28.08	A	28,775	D
Common Stock^F7,F2	Feb 13, 2015	S	11,600	$55.86	D	17,175	D
Common Stock^F2	Feb 13, 2015	M	22,100	$15.30	A	39,275	D
Common Stock^F9,F2	Feb 13, 2015	S	22,100	$55.86	D	17,175	D
Common Stock^F2	Feb 13, 2015	M	12,859	$23.51	A	30,034	D
Common Stock^F11,F2	Feb 13, 2015	S	12,859	$55.76	D	17,175	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (Right to Buy)^F12	$32.59	Feb 13, 2015	M	7,500	D	—	May 13, 2015	Common Stock	7,500	D
Stock Option (Right to Buy)^F13	$39.10	Feb 13, 2015	M	7,500	D	—	May 12, 2016	Common Stock	7,500	D
Stock Option (Right to Buy)^F14	$28.08	Feb 13, 2015	M	11,600	D	—	May 9, 2018	Common Stock	11,600	D
Stock Option (Right to Buy)^F15	$15.30	Feb 13, 2015	M	22,100	D	—	May 22, 2016	Common Stock	22,100	D
Stock Option (Right to Buy)^F16	$23.51	Feb 13, 2015	M	12,859	D	—	May 13, 2017	Common Stock	12,859	D

Explanation of responses

F1Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2005, under the Issuer's Amended and Restated 1998 Stock Option Plan, as amended (the "2005 Grant"), in a transaction exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Act").
F10Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2010, under the Issuer's 2006 Plan (the "2010 Grant"), in a transaction exempt under Rule 16b-3 of the Act.
F11The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.67 to $55.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F12The 2005 Grant became exercisable in 33 1/3% increments on each of the first, second and third anniversaries of May 13, 2005, the grant date.
F13The 2006 Grant became exercisable in 33 1/3% increments on each of the first, second and third anniversaries of May 12, 2006, the grant date.
F14The 2008 Grant became exercisable in 33 1/3% increments on each of the first, second and third anniversaries of May 9, 2008, the grant date.
F15The 2009 Grant became exercisable in 33 1/3% increments on each of the first, second and third anniversaries of May 22, 2009, the grant date.
F16The 2010 Grant became exercisable in 33 1/3% increments on each of the first, second and third anniversaries of May 13, 2010, the grant date.
F2Includes shares held by the Frederick C. Yeager Revocable Trust, for which the reporting person is a trustee and beneficiary.
F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.78 to $56.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F4Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 12, 2006 (the "2006 Grant"), under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2006 Plan"), in a transaction exempt under Rule 16b-3 of the Act.
F5The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.89 to $56.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F6Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 9, 2008, under the Issuer's 2006 Plan (the "2008 Grant"), in a transaction exempt under Rule 16b-3 of the Act.
F7The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.73 to $56.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F8Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 22, 2009, under the Issuer's 2006 Plan (the "2009 Grant"), in a transaction exempt under Rule 16b-3 of the Act.
F9The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.75 to $55.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.